Vektor Medical Secures $16 Million Series A Funding
Digital Health Global
FEBRUARY 5, 2024
Investment Marks a Significant Milestone in Advancing AI-Based Arrhythmia Care SAN DIEGO–(BUSINESS WIRE)– Vektor Medical , a pioneer in non-invasive, AI-based arrhythmia analysis technology, today announced a $16 million Series A investment co-led by Solas BioVentures and TVM Capital Life Science.
Let's personalize your content